Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123246) titled 'Morphometric Analysis of Meibomian Glands and Levator Palpebrae Superioris in Thyroid Eye Disease with Upper Eyelid Retraction: An AI-Driven Quantitative Approach' on April 23.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Eye Hospital, Wenzhou Medical University

Condition: Thyroid eye disease upper eyelid retraction

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-25

Target Sample Size: NA:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=317849

Disclaimer: Curated by HT Syndication....